Quick Answer
CORCEPT THERAPEUTICS INC reported Long-Term Debt of $0.00 for fiscal year 2016.
CORCEPT THERAPEUTICS INC Long-Term Debt — Annual History
| Fiscal Year | Long-Term Debt | YoY Change |
|---|---|---|
| 2016 | $0.00 | -100.0% |
| 2015 | $12.53M | -48.8% |
| 2014 | $24.46M | -16.6% |
| 2013 | $29.32M | +1.0% |
| 2012 | $29.03M | — |
Quarterly Long-Term Debt
| Quarter Ending | Long-Term Debt | YoY | QoQ |
|---|---|---|---|
| September 30, 2016 | $0.00 | -100.0% | -100.0% |
| June 30, 2016 | $3.74M | -80.7% | -57.1% |
| March 31, 2016 | $8.72M | -60.6% | -30.4% |
| December 31, 2015 | $12.53M | -48.8% | -22.3% |
| September 30, 2015 | $16.13M | -37.9% | -16.8% |
| June 30, 2015 | $19.40M | -29.8% | -12.3% |
| March 31, 2015 | $22.13M | -21.6% | -9.6% |
| December 31, 2014 | $24.46M | -16.6% | -5.9% |
- CORCEPT THERAPEUTICS INC showed a decrease of -100.0% in Long-Term Debt compared to the prior fiscal year.
- Over the 2012–2016 period, CORCEPT THERAPEUTICS INC’s long-term debt has declined by 100.0% (from $29.03 million to $0.00).
- The most recent figure is from CORCEPT THERAPEUTICS INC’s fiscal year 2016 report (Form 10-K), filed with the SEC on March 6, 2017.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: